Posters
Most Viewed
Poster
2024 ASCO Annual Meeting
Three-year follow-up data from KEYNOTE-966: Pembrolizumab (pembro) plus gemcitabine and cisplatin (gem/cis) compared with gem/cis alone for patients (pts) with advanced biliary tract cancer (BTC).
First Author: Richard S. Finn
Date: Jun 1, 2024
Poster
2024 ASCO Annual Meeting
Zanidatamab in previously-treated HER2-positive (HER2+) biliary tract cancer (BTC): Overall survival (OS) and longer follow-up from the phase 2b HERIZON-BTC-01 study.
First Author: Shubham Pant
Date: Jun 1, 2024
Poster
2023 ASCO GU Cancers Symposium
Phase 3 LITESPARK-022: Pembrolizumab (pembro) plus hypoxia-inducible factor 2α (HIF-2α) inhibitor belzutifan as adjuvant treatment for clear cell renal cell carcinoma (ccRCC).
First Author: Toni K. Choueiri
Date: Feb 18, 2023
Poster
2024 ASCO Genitourinary Cancers Symposium
First-in-human phase 1 study of CC-94676, a first-in-class androgen receptor (AR) ligand-directed degrader (LDD), in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
First Author: Dana E. Rathkopf
Date: Jan 25, 2024
Recently Published
Poster
2024 ASCO Quality Care Symposium
Accelerating access: The power of gold carding in reducing treatment delays.
First Author: Gunjan Sharma
Date: Sep 28, 2024
Poster
2024 ASCO Quality Care Symposium
The role of income level in outcomes and treatment for patients with fibrolamellar hepatocellular carcinoma.
First Author: Jaikin Patel
Date: Sep 28, 2024
Poster
2024 ASCO Quality Care Symposium
Revolutionizing cancer survivorship: Using human-centered design to build an innovative model for whole-person healing.
First Author: Michelle Payan
Date: Sep 28, 2024
Poster
2024 ASCO Quality Care Symposium
Improving advance care planning outcomes through social work and provider collaboration.
First Author: Nicole Marcouiller
Date: Sep 28, 2024
Poster
2024 ASCO Quality Care Symposium
Leveraging the electronic health record patient portal to enhance clinical trial recruitment.
First Author: Finnegan Hall
Date: Sep 28, 2024
Poster
2024 ASCO Quality Care Symposium
Opioid tapering and discontinuation for head and neck cancer (HNC) survivors.
First Author: Talya Salz
Date: Sep 28, 2024
Poster
2024 ASCO Quality Care Symposium
AI-enabled ACP on inpatient oncology: Feasibility, acceptability and impact on workflow.
First Author: Ali Raza Khaki
Date: Sep 28, 2024
Poster
2024 ASCO Quality Care Symposium
A scoping review capturing financial experiences of cancer survivors: Are we on the same page?
First Author: Elyse Richelle Park
Date: Sep 28, 2024